Rong Yin

9.7k total citations · 1 hit paper
211 papers, 6.2k citations indexed

About

Rong Yin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rong Yin has authored 211 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 73 papers in Cancer Research and 50 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rong Yin's work include Cancer-related molecular mechanisms research (40 papers), RNA modifications and cancer (39 papers) and Lung Cancer Treatments and Mutations (23 papers). Rong Yin is often cited by papers focused on Cancer-related molecular mechanisms research (40 papers), RNA modifications and cancer (39 papers) and Lung Cancer Treatments and Mutations (23 papers). Rong Yin collaborates with scholars based in China, United States and Canada. Rong Yin's co-authors include Lin Xu, Mantang Qiu, Siwei Wang, Tongyan Liu, Chencheng Han, Youtao Xu, Jingwen Hu, Zhifei Ma, Feng Jiang and Panqi Fang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Rong Yin

196 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

2019 651 citations Tongyan Liu, Chencheng Han et al. profile →

Peers

Countries citing papers authored by Rong Yin

Since Specialization

Citations

This map shows the geographic impact of Rong Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Yin more than expected).

Fields of papers citing papers by Rong Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Yin. The network helps show where Rong Yin may publish in the future.

Co-authorship network of co-authors of Rong Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Yin. A scholar is included among the top collaborators of Rong Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Yin. Rong Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors influencing the perceived usability of line pay: An extended technology acceptance model approach 2025 ·Acta Psychologica ·Yogi Tri Prasetyo, (unknown), K.-J. Chuang, Rong Yin, (unknown), Yuxuan Zhang, (unknown), (unknown), Maela Madel L. Cahigas, Reny Nadlifatin, Ma. Janice J. Gumasing	2
2	High-valent metal oxide-induced exceptional HTHP corrosion resistance in TiVNbTa refractory high-entropy alloy 2025 ·Materials Today Communications ·Tao Yu, Juan Li, Qingdong Qin, Rong Yin, Honglong Zhao, (unknown), Chuang Yang	0
3	Human intestinal fungus Clavispora lusitaniae attenuates colitis through Pyruvate decarboxylase-derived Indole-3-ethanol 2025 ·Nature Communications ·Fan Wu, Yan Wang, (unknown), Zhichao Xu, Shenghui Li, Yu Li, Rong Yin, Jiamin Li, Zhenlong Yu, Yuzhuo Wu, Xiangge Tian, Xiaoying Feng, Xiaokui Huo, Chao Wang, Xiaochi Ma	0
4	Transfer of Damaged Mitochondria from Cancer Cells to Cancer-Associated Fibroblasts Promotes Tyrosine Kinase Inhibitor Tolerance in EGFR -Mutant Lung Cancer 2025 ·Cancer Research ·Tongyan Liu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Youtao Xu, Wenjia Xia, (unknown), Rong Yin	0
5	Minor element doping effects on microstructure and mechanical properties of a non-equiatomic FeNiCoCr high-entropy alloy 2024 ·Materials Characterization ·Rong Yin, Patrick J. Masset, Kefu Gan, (unknown), L.B. Liu	4
6	Fallopian tube cancer with inguinal lymph node metastasis as the first symptom: A case study and review of the literature 2024 ·International Journal of Surgery Case Reports ·Qing Su, Shichao Han, Rong Yin, Qiyu Yang, Zhuo Pan	1
7	Optimized segmented regression models for the transition period of intervention effects 2023 ·Global Health Research and Policy ·(unknown), Kunpeng Wu, (unknown), Rong Yin, Yi Zhang, (unknown), Qi Wang, Wen Chen	1
8	Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing 2023 ·Journal of Experimental & Clinical Cancer Research ·Zhifei Ma, Hao Chen, Zhijun Xia, Jing You, Chencheng Han, Siwei Wang, Wenjia Xia, Yongkang Bai, Tongyan Liu, Lin Xu, Guoren Zhou, Youtao Xu, Rong Yin	11
9	Targeting phenylpyruvate restrains excessive NLRP3 inflammasome activation and pathological inflammation in diabetic wound healing 2023 ·Cell Reports Medicine ·Dongming Lv, Xiaoling Cao, Zhong Li, Yunxian Dong, (unknown), (unknown), Hailin Xu, Zhiyong Wang, Hao Yang, Rong Yin, Miao Chen, Chao Ke, Zhicheng Hu, Wuguo Deng, Bing Tang	84
10	Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer 2022 ·American Journal of Respiratory and Critical Care Medicine ·Siwei Wang, (unknown), Ming Li, Hua Bao, Xin Chen, Meng Zhu, Rui Liu, (unknown), S Samuel Yang, Xue Wu, Yang Shao, Lin Xu, Rong Yin	43
11	Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle 2021 ·Cancer Research ·Meng Zhu, Tianpei Wang, Yanqian Huang, Xiaoyu Zhao, Yuqing Ding, Mengyi Zhu, Mengmeng Ji, Cheng Wang, Juncheng Dai, Rong Yin, Lin Xu, Hongxia Ma, Qingyi Wei, Guangfu Jin, Zhibin Hu, Hongbing Shen	65
12	Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma 2021 ·Cancer Communications ·Quanli Zhang, Run Shi, Yongkang Bai, Lijuan Meng, Jingwen Hu, Hongyu Zhu, Tongyan Liu, (unknown), Siwei Wang, Jie Wang, Lin Xu, Guoren Zhou, Rong Yin	26
13	MIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma 2021 ·Cell Death and Disease ·Chencheng Han, Hong Li, Zhifei Ma, (unknown), (unknown), Siwei Wang, Panqi Fang, Xiang Li, Hao Chen, Tongyan Liu, Lin Xu, Jie Wang, (unknown), Rong Yin	33
14	Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression 2020 ·SHILAP Revista de lepidopterología ·Rong Yin, Jianjun Liu, (unknown), (unknown)	1
15	Knocking down PFL can improve myocardial ischemia/reperfusion injury in rats by up-regulating heat shock protein-20 2020 ·SHILAP Revista de lepidopterología ·Rong Yin, Hong You, Yanmin Wu, (unknown), Wen Gu, Jian Shen	3
16	Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib 2019 ·Lung Cancer ·Jun Zhao, Gen Lin, Minglei Zhuo, (unknown), Liyun Miao, Likun Chen, Aiping Zeng, Rong Yin, Yangming Ou, Zhihui Shi, Jie Yin, Wen Gao, Jianhua Chen, Xiangdong Zhou, Yong Zeng, Xiang Liu, (unknown), Rongrong Chen, Xuefeng Xia, David P. Carbone	30
17	Four transcription profile–based models identify novel prognostic signatures in oesophageal cancer 2019 ·Journal of Cellular and Molecular Medicine ·Tongyan Liu, Panqi Fang, Chencheng Han, Zhifei Ma, Weizhang Xu, Wenjia Xia, Jingwen Hu, Youtao Xu, Lin Xu, Rong Yin, Siwei Wang, Qin Zhang	15
18	The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma 2018 ·Cancer Research ·Mantang Qiu, Wenjia Xia, Rui Chen, Siwei Wang, Youtao Xu, Zhifei Ma, Weizhang Xu, Erbao Zhang, Jie Wang, Fang Tian, Jingwen Hu, Gaochao Dong, Rong Yin, Jun Wang, Lin Xu	215
19	Profiling expression of coding genes, long noncoding RNA, and circular RNA in lung adenocarcinoma by ribosomal RNA‐depleted RNA sequencing 2018 ·FEBS Open Bio ·Xiangxiang Ding, Shuai Zhang, Xiao Li, Changjiang Feng, Qi Huang, Shaodong Wang, Siwei Wang, Wenjia Xia, Fan Yang, Rong Yin, Lin Xu, Mantang Qiu, Ming Li, Jun Wang	61
20	Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non–Small Cell Lung Cancer: A Meta-analysis 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Mantang Qiu, Jie Wang, Youtao Xu, Xiangxiang Ding, Ming Li, Feng Jiang, Lin Xu, Rong Yin	156

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact